Release Date: 20/03/09 19:08 Summary: Full Year Statutory Accounts Price Sensitive: Yes Download Document 605.86KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%